PTJ
GBIO

Paul Tudor Jones’s Generation Bio GBIO Stock Holding History

Paul Tudor Jones’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,808
Closed -$121K – 2617
2023
Q1 		$121K Buy
+2,808
New +$136K ﹤0.01% 2241
2022
Q4 		– Sell
-2,823
Closed -$150K – 2546
2022
Q3 		$150K Buy
2,823
+44
+2% +$2.75K ﹤0.01% 2126
2022
Q2 		$182K Sell
2,779
-39
-1% -$2.55K ﹤0.01% 1848
2022
Q1 		$207K Buy
2,818
+757
+37% +$43.9K ﹤0.01% 1757
2021
Q4 		$146K Buy
+2,061
New +$360K ﹤0.01% 2208

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Paul Tudor Jones's GBIO Position: Q2 2023 in Review

Paul Tudor Jones sold out of Generation Bio (GBIO) in Q2 2023, closing a stake of 2,808 shares — an estimated $121K sold.

Paul Tudor Jones first reported a position in GBIO in Q4 2021 and held it in 5 quarters. The position peaked at $207K in Q1 2022. 79 funds tracked by Wall St. Rank hold GBIO as of Q2 2023.

  • Paul Tudor Jones reported no remaining Generation Bio position as of Q2 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 2,808 Generation Bio shares in Q2 2023, an estimated $121K.
  • Paul Tudor Jones first reported a position in Generation Bio in Q4 2021 and held it in 5 quarters.
  • Paul Tudor Jones's Generation Bio position peaked at $207K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Generation Bio as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.